BCAL Diagnostics

BCAL Diagnostics Tangible Book Value per Share

The Tangible Book Value per Share of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is 0.02 AUD. In the previous year, Tangible Book Value per Share was 0.02 AUD — a change of -27.57% (lower).

Tangible Book Value per Share

0.02AUD

YoY

-27.57%

Last updated:

Tangible Book Value per Share of BCAL Diagnostics is 2025 0.02 AUD. Tangible Book Value per Share of BCAL Diagnostics was 2024 0.02 AUD. It decreases by -27.57% lower compared to the previous year.

The BCAL Diagnostics Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
-0.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.00 AUD
Jan 1, 2021
0.01 AUD
Jan 1, 2022
0.03 AUD
Jan 1, 2023
0.01 AUD
Jan 1, 2024
0.02 AUD
Jan 1, 2025
0.02 AUD
The BCAL Diagnostics Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.02AUD-27.57%
0.02AUD+64.72%
0.01AUD-45.91%
0.03AUD+167.26%
0.01AUD+721.80%
0.00AUD-10.10%
0.00AUD-696.09%
-0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

Tangible Book Value per Share of BCAL Diagnostics is 0.02 AUD in 2025.

Tangible Book Value per Share of BCAL Diagnostics changed from 0.02 AUD to 0.02 AUD, representing a -27.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — BCAL Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BCAL Diagnostics